<DOC>
	<DOCNO>NCT00712868</DOCNO>
	<brief_summary>To demonstrate safety acceptability gynaecological formulation .</brief_summary>
	<brief_title>Acceptability Lactacyd Femina</brief_title>
	<detailed_description />
	<criteria>Integral skin test region Pregnancy breastfeed woman Use antiinflammatory immunesuppression drug Topical medication use test region Active cutaneous gynaecological disease may interfere study result Personal history allergic disease area treat Allergic atopic history The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>